INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK ... Michael Dickinson, MBBS, FRACP, Lead of the Aggressive Lymphoma Disease Group at Peter ...
The adoptive transfer of chimeric antigen receptor (CAR) T-cells has achieved remarkable therapeutic responses ... like cytokine release syndrome and neurotoxicity, as commonly seen in treated cancer ...